Clinical microbiology of cystic fibrosis
- 1 March 1984
- journal article
- Published by Elsevier in Clinical Microbiology Newsletter
- Vol. 6 (6), 39-42
- https://doi.org/10.1016/s0196-4399(84)80047-1
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosisAntimicrobial Agents and Chemotherapy, 1982
- RESPIRATORY INFECTIONS IN CYSTIC FIBROSIS PATIENTS CAUSED BY VIRUS, CHLAMYDIA AND MYCOPLASMA–POSSIBLE SYNERGISM WITH PSEUDOMONAS AERUGINOSAActa Paediatrica, 1981
- MucoidEscherichia coliin Cystic FibrosisNew England Journal of Medicine, 1981
- USE OF SELECTIVE MEDIA IN BACTERIOLOGICAL INVESTIGATION OF PATIENTS WITH CHRONIC SUPPURATIVE RESPIRATORY INFECTIONThe Lancet, 1980
- MECHANISMS OF AMPICILLIN RESISTANCE IN HqMOPHILUS INFLUENZq FROM RESPIRATORY TRACTThe Lancet, 1980
- BACTERIAL CONTENT AND IONIC COMPOSITION OF SPUTUM IN CYSTIC FIBROSISThe Lancet, 1978
- Mucoid Pseudomonas aeruginosaPublished by American Medical Association (AMA) ,1976
- Pseudomonas carrier rates of patients with cystic fibrosis and of members of their familiesThe Journal of Pediatrics, 1976
- In vivo penetration of antibiotics into sputum in cystic fibrosis.Archives of Disease in Childhood, 1968
- An atypical Pseudomonas aeruginosa associated with cystic fibrosis of the pancreasThe Journal of Pediatrics, 1966